Concepedia

Curt Hartleben-Matkin

CH

Statistics

Publications

4

Citations

63

H-Index

4

Active since

2010

Affiliations

Laboratorios Sophia (Mexico)(Current)

Universidad de Guadalajara

Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes

Curt Hartleben-Matkin is an author at Laboratorios Sophia (Mexico) specializing in pharmacotherapy, ophthalmic surgery, and ophthalmology.

ORCID

Publications per year

2010–2018

4

Publications

4

Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study

Alfonso García-López, José A Paczka, Jesús Jiménez-Román et al. · BMC Ophthalmology · 2014 · 21 citations · Full text

, , +14

The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.

Leopoldo Martín Baiza-Durán, Jaime Álvarez-Delgado, Angélica Yussett Contreras-Rubio et al. · PubMed · 2010 · 16 citations

, , +5

A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

Curt Hartleben-Matkin, Juan Camilo Parra, Amy L. Batoosingh et al. · Journal of Ophthalmology · 2017 · 14 citations · Full text

, , +15

A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma

Francisco Gómez-Aguayo, José A Paczka, Rubén Leñero-Córdova et al. · Ophthalmology and Therapy · 2018 · 12 citations · Full text

, , +16

1–4 of 4